Nanjing Medlander Shares Owned By Institutions vs. Price To Sales

688273 Stock   25.80  0.14  0.55%   
Considering Nanjing Medlander's profitability and operating efficiency indicators, Nanjing Medlander Medical may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Nanjing Medlander's ability to earn profits and add value for shareholders.
For Nanjing Medlander profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nanjing Medlander to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nanjing Medlander Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nanjing Medlander's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nanjing Medlander Medical over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Nanjing Medlander's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nanjing Medlander is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanjing Medlander's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Nanjing Medlander Medical Price To Sales vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Nanjing Medlander's current stock value. Our valuation model uses many indicators to compare Nanjing Medlander value to that of its competitors to determine the firm's financial worth.
Nanjing Medlander Medical is number one stock in shares owned by institutions category among its peers. It also is number one stock in price to sales category among its peers fabricating about  0.79  of Price To Sales per Shares Owned By Institutions. The ratio of Shares Owned By Institutions to Price To Sales for Nanjing Medlander Medical is roughly  1.27 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanjing Medlander by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanjing Medlander's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Nanjing Price To Sales vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Nanjing Medlander

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
8.60 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Nanjing Medlander

P/S

 = 

MV Per Share

Revenue Per Share

 = 
6.78 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Nanjing Price To Sales Comparison

Nanjing Medlander is currently under evaluation in price to sales category among its peers.

Nanjing Medlander Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Nanjing Medlander, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nanjing Medlander will eventually generate negative long term returns. The profitability progress is the general direction of Nanjing Medlander's change in net profit over the period of time. It can combine multiple indicators of Nanjing Medlander, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Net Interest Income14.4 M15.1 M
Interest Income14.9 M15.6 M
Operating Income74.4 M93.4 M
Net Income From Continuing Ops92.5 M92.6 M
Income Before Tax101.5 M103 M
Net Income89.8 M88.6 M

Nanjing Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Nanjing Medlander. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nanjing Medlander position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nanjing Medlander's important profitability drivers and their relationship over time.

Use Nanjing Medlander in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nanjing Medlander position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanjing Medlander will appreciate offsetting losses from the drop in the long position's value.

Nanjing Medlander Pair Trading

Nanjing Medlander Medical Pair Trading Analysis

The ability to find closely correlated positions to Nanjing Medlander could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nanjing Medlander when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nanjing Medlander - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nanjing Medlander Medical to buy it.
The correlation of Nanjing Medlander is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nanjing Medlander moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nanjing Medlander Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nanjing Medlander can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Nanjing Medlander position

In addition to having Nanjing Medlander in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Banks - Regional Thematic Idea Now

Banks - Regional
Banks - Regional Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banks - Regional theme has 19 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks - Regional Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Nanjing Stock

To fully project Nanjing Medlander's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Nanjing Medlander Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Nanjing Medlander's income statement, its balance sheet, and the statement of cash flows.
Potential Nanjing Medlander investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Nanjing Medlander investors may work on each financial statement separately, they are all related. The changes in Nanjing Medlander's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nanjing Medlander's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.